Cell-cycle regulatory proteins, and uses related thereto
US6486131B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jan 30, 1998 |
| Grant date | Nov 26, 2002 |
| Priority date | — |
| Expiry date | Jan 30, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4739
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to the discovery in eukaryotic cells, particularly mammalian cells, of a novel family of cell-cycle regulatory proteins (“CCR-proteins”). As described herein, this family of proteins includes a polypeptide having an apparent molecular weight of 16 kDa, and a polypeptide having an apparent molecular weight of approximately 15 kDa, each of which can function as an inhibitor of cell-cycle progression, and therefore ultimately of cell growth. Thus, similar to the role of p21 to the p53 checkpoint, the subject CCR-proteins may function coordinately with the cell-cycle regulatory protein, retinoblastoma (RB). Furthermore, the CCR-protein family includes a protein having an apparent molecular weight of 13.5 kDa (hereinafter “p13.5”). The presumptive role of p13.5, like p16 and p15, is in the regulation of the cell-cycle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.